Materials and Methods
This prospective observational study was carried out in three cardiac centres in Dhaka city, Bangladesh, between January 2006 to December 2009. A total of 50 pregnant women with mitral stenosis (MS) were included in the study. Exclutions included 1) incomplete records, 2) prosthetic heart valve and therapeutic abortion for non-cardiac reasons. Majority of patients were supervised in the cardio obstetric clinic of the respective cardiac centre under joint supervision of an obstetrician and cardiologist. A questionnaire was prepared to collect data of the index population. For each studied patients age, obstetrical and medical history of prenatal care and year of pregnancy were recorded.
Maternal outcome (deterioration of NYHA class, maternal morbidity and mortality, valve thrombosis need for interventional or surgical intervention in pregnancy) and fetal outcome (birth weight, prematurely, congenital malformation) were documented separately.
The data was analyzed and calculated to evaluate maternal as well as fetal outcome. And the results were expressed in the form of table and graph. All values were presented as mean ±SD.
Results
The mean age of the study population was 26±4.5 and most of them were in the age group of 16-30 years (Table-I) . Table 1 also revealed other demographic information and baseline characteristics of the studied cases. 38 (76%) were in the NYHA functional class I-II and 12 (24%) were in the class III-IV. 30 (60%) patients had single mitral valve involvement. Surgical or interventional correction of the underlying lesion prior to pregnancy was done in 7(14%) patients of which 6 (12%) had mitral valvotomy and 1 (2%) had valve replacement (Table-II) .
Maternal complications included anaemia in 4 (8%) and gestational diabetes in 2 (4%) patients. Cardiac complications were observed and there were pulmonery edema in 5 (10%); atrial fibrillation in 4(8%), thromboembolism in 2(4%) and infective endocarditis in 1(2%) woman. There was 1 (2%) maternal death (table-III) . Table-IV) . Table- 
Discussion
Heart disease remains the third most common nonobstetric cause of maternal death following hypertension and pulmonary embolism. 5 The commonest cardiac lesion is rheumatic origin followed by the congenital one. 6 The results of our study demonstrate a significant impact of MS on both maternal and fetal outcomes.
Maternal outcome : Women with MS had a high rate of clinical deterioration and a marked increase in morbid events during pregnancy, including CHF, arrhythmias and need to either initiate or increase cardiovascular drug therapy or to hospitalize patients during pregnancy. The haemodynamic change that occur during pregnancy have a profound effect on the patient with cardiac disease. [7] [8] [9] [10] [11] 12 Haemodynamic changes increases cardiac work. Combined effect of haemodynamic changes and heart may exceed the limited functional capacity of heart. 7, 11 When this happen, sudden death or more commonly congestive heart failure (CHF) will occur. As a result of the deleterious effects of pregnancy on cardiac disease maternal mortality may be high as 10% for all cardiac problem. 7, 9, 10, 13, 14, 15 There are several periods during pregnancy when the danger of cardiac detoriation is specially high. The first is between 12 and 32 weeks of gestation. The most critical period is between 28 and 32 weeks. About 50% patients develop heart failure in antepartum period. 7, 8, 9, 10, 11, 6, 7, 8, 14, 16 The second dangerous period is during labor and delivery. The large and increase in blood volume is more then many cardiac patients can tolerate and CHF occur infrequently. Particularly predispose CHF. [7] [8] [9] [10] [11] [12] 14, 15, 17, 18 Final dangerous time for the pregnant patients with MS is 4 to 5 day after delivery. CHF after develops at this period.
Fetal outcome :
In addition to the effect on maternal morbidity, the present study also demonstrated an effect of MS on fetal outcome. Pregnancy in our patients was associated with an increased incidence of IUGR, preterm deliveries, and lower birth weight, especially in case with moderate and severe stenosis of the mitral valve. Hemodynamic compromise secondary to valvular stenosis and the resulting decrease in uterine blood flow are probable explanations for the high incidence of impaired intrauterine fetal growth seen in this study.
Valvular repair during pregnancy: Valvular repair, either surgically or by percutaneous balloon valvuloplasty, is the procedure of choice in symptomatic, nonpregnant patients with MS. Successful cardiovascular surgery has been reported during pregnancy. 20, 21 In our study 2(4%) patients had closed mitral valvotomy and 4(8%) patients had balloon mitral valvuloplasty.
Conclusion
Valvular heart disease (VHD) may have a significant impact on the course and outcome of pregnancy with implication for fetal as well as maternal health. Optimally serious symptomatic VHD should be detected and treated before pregnancy because of its deleterious impact on maternal and fetal outcome of pregnancy. The result of the present study demonstrate an important effect of MS on both metarnal and fetal outcome of pregnancy. The results of the study indicate that whether a pregnant women is known to have MS or is diagnosed during pregnancy, however, it is imperative that she is managed by an experienced multidisciplinary team including an obstetrician/ perinatologist, cardiologist and obstetric anesthesiologist. Although medical therapy may alleviate symptoms of heart failure in some patients, definitive intervention either with percutaneous balloon valvuloplasty or with surgical valve replacement may be necessary. The possible benefit of the procedures, however, should be carefully weighed against its maternal risks during pregnancy.
